Neximmune

Neximmune EV/FCF

The EV/FCF (Enterprise Value to Free Cash Flow) of Neximmune (NEXI) as of Oct 19, 2026 is 0.66. In the previous year, EV/FCF (Enterprise Value to Free Cash Flow) was 1.70 — a change of -61.14% (lower).

EV/FCF

0.66

YoY

-61.14%

Last updated:

EV/FCF (Enterprise Value to Free Cash Flow) of Neximmune is 2022 0.66 . EV/FCF (Enterprise Value to Free Cash Flow) of Neximmune was 2021 1.70 . It decreases by -61.14% lower compared to the previous year.

The Neximmune EV/FCF history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EV/FCF
Date
EV/FCF
Jan 1, 2018
1.00 USD
Jan 1, 2019
0.49 USD
Jan 1, 2020
-0.52 USD
Jan 1, 2021
1.70 USD
Jan 1, 2022
0.66 USD
The Neximmune EV/FCF history
YEAREV/FCFYoY
0.66-61.14%
1.70-428.82%
-0.52-205.47%
0.49-50.99%
1.00—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Neximmune Stock analysis

What does Neximmune do? Neximmune Inc, trading under ticker NEXI, is a US-based biotechnology company headquartered in Gaithersburg. Founded in 2021, the company went public on February 12, 2021. It employs 50 people and operates in the Health Care sector. Neximmune focuses on developing immunotherapies using its Artificial Immune Modulation (AIM) platform, which employs nanoparticles to direct T cell responses. The company's product candidates include NEXI-001 for acute myeloid leukemia and NEXI-002 for multiple myeloma. Its AIM technology constructs synthetic dendritic cells to generate targeted immune responses. The company is clinical-stage, developing treatments for oncology and autoimmune disorders. Neximmune is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Neximmune stock

EV/FCF (Enterprise Value to Free Cash Flow) of Neximmune is 0.66 in 2022.

EV/FCF (Enterprise Value to Free Cash Flow) of Neximmune changed from 1.70 to 0.66, representing a -61.14% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EV/FCF (Enterprise Value to Free Cash Flow) Neximmune since 2006 – with annual values, charts, and detailed analysis.

The EV/FCF ratio measures the enterprise value relative to free cash flow. It captures the true cash-generating ability of a business.

To evaluate EV/FCF (Enterprise Value to Free Cash Flow)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EV/FCF (Enterprise Value to Free Cash Flow).

A 'good' varies by industry and company stage. On Eulerpool, you can compare EV/FCF (Enterprise Value to Free Cash Flow)'s Neximmune with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — Neximmune

All Key Metrics — Neximmune